News

Deal Announcements

Atterocor Raises Series A Venture Capital

Monday, August 6, 2012 5:36:00 AM PDT | VentureDeal
Ann Arbor, Michigan  --  Pharmaceutical technology company Atterocor has garnered $16 million in its first round of institutional venture capital financing.

Atterocor is developing treatments for adrenal cancer.

Frazier Healthcare Ventures and 5AM Ventures co-led the round, which included other undisclosed investors.

The company said it would use the financing to support the accelerated development of its lead program.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1